Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03108495
Title Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Iovance Biotherapeutics, Inc.

cervical squamous cell carcinoma

cervical adenosquamous carcinoma

cervical adenocarcinoma



Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU

No variant requirements are available.